OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024

January 19, 2024

https://www.globenewswire.com/news-release/2024/01/05/2804704/0/en/OKYO-Pharma-to-Present-at-the-Biotech-Showcase-Conference-in-San-Francisco-January-8-10-2024.html

LONDON and NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and for neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, is pleased to announce that it will be presenting at Biotech Showcase in San Francisco, January 8-10 2024. The OKYO management team will also be participating in one-on-one partnering meetings throughout the conference.

Read more at globenewswire.com

Related news for (OKYO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.